AzTrials
AzTrials

GallstonesNCT01039129

Hybrid Transvaginal-Transabdominal Endoscopic Surgery

A study testing Endoscopic Cholecystectomy, Endoscopic Appendectomy and Endoscopic Peritoneoscopy in people with Gallstones and Appendicitis, run by St. Luke's-Roosevelt Hospital Center at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The is a pilot study to evaluate the safety and efficacy of hybrid transvaginal-transabdominal procedures. Diagnostic peritoneoscopy (visualizing the inside of the abdomen), appendectomy (removal of the appendix), and cholecystectomy (removal of the gallbladder) will be performed through a vaginal incision with an… Read more about this study

Who is it for?
Ages 18 to 60 years, women only
Conditions the study is for
Gallstones, Appendicitis, Pelvic Pain
What is being tested?
Endoscopic Cholecystectomy, Endoscopic Appendectomy and Endoscopic Peritoneoscopy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Dec 2009to Oct 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Chronic or early appendicitis
  • Symptomatic gallstones
  • Suspicious abdominal mass/nodule
  • Female
  • Age 18-60 years
  • ASA Class I or II

Who cannot join

  • Pregnant women
  • History of previous abdominal, pelvic, or vaginal surgery
  • History of previous abdominal or pelvic radiation therapy
  • History of fibroid uterus
  • History of endometriosis
  • History of large ovarian cyst
  • History of unexplained vaginal bleeding or dyspareunia

Trial locations and contacts

1 site in 1 country.

United States1 site
  • St. Luke's-Roosevelt Hospital Center

    New York, New York, 10025

Other trials in United States

About this study

The is a pilot study to evaluate the safety and efficacy of hybrid transvaginal-transabdominal procedures. Diagnostic peritoneoscopy (visualizing the inside of the abdomen), appendectomy (removal of the appendix), and cholecystectomy (removal of the gallbladder) will be performed through a vaginal incision with an additional small incision in the umbilicus.

Being tested
Endoscopic Cholecystectomy, Endoscopic Appendectomy, Endoscopic Peritoneoscopy
Keywords
Gallstones, Appendicitis, Pelvic pain, Peritoneal mass
Medical subject headings
Gallstones, Appendicitis, Pelvic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic CholecystectomyProcedure or surgery

    An incision will be made in the vagina and a flexible surgical camera (endoscope) and instruments will be introduced. The surgical procedure for each given arm will be performed with the aid of an additional surgical instrument inserted through a small incision in the umbilicus.

  • Endoscopic AppendectomyProcedure or surgery

    An incision will be made in the vagina and a flexible surgical camera (endoscope) and instruments will be introduced. The surgical procedure for each given arm will be performed with the aid of an additional surgical instrument inserted through a small incision in the umbilicus

  • Endoscopic PeritoneoscopyProcedure or surgery

    A diagnostic peritoneoscopy with or without biopsy for any indication

Study groups in NCT01039129
Study groupRoleWhat they receive
Endoscopic CholecystectomyExperimental20 patients in this arm will undergo cholecystectomy, or removal of the gallbladder, through this experimental approach. This arm will compose of patients with symptomatic gallstones (cholelithiasis).
Receives: Procedure: Endoscopic Cholecystectomy
Endoscopic AppendectomyExperimentalParticipants will with chronic appendicitis will undergo appendectomy through this experimental approach.
Receives: Procedure: Endoscopic Appendectomy
Endoscopic PeritoneoscopyExperimental20 patients in this arm will undergo diagnostic peritoneoscopy with or without biopsy for any indication.
Receives: Procedure: Endoscopic Peritoneoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Technical success

    Measured: intra-operative

  2. Complication

    Measured: 1 month

Secondary outcomes (2)
  1. Operative time

    Measured: intra-operative

  2. Sexual function

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2009 (estimated)
  2. Study startDec 2009
  3. Primary completionOct 2012
  4. Study completionOct 2012

Why it stopped: unable to recruit participants

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01039129
Sponsor's protocol ID
SLR IRB#09-136
Status last verified
Aug 2015
First submitted
22 Dec 2009
Last updated
21 Aug 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopic Cholecystectomy, Endoscopic Appendectomy and Endoscopic Peritoneoscopy in people with Gallstones and Appendicitis, run by St. Luke's-Roosevelt Hospital Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 21 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Technical success (time frame: intra-operative). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in